Drug Group Lifts J&J; Shares Still Overvalued
July 19, 2016 at 12:00 PM EDT
We plan to raise our fair value for the pharma giant after second-quarter results, but valuation remains rich.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.